Patents by Inventor Kyung O Johanson

Kyung O Johanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-??humanized monoclonal antibodies
    Patent number: 7504102
    Abstract: This invention relates to novel humanized and other recombinant or engineered antibodies or monoclonal antibodies to the vitronectin ?v?3 receptor and to the genes encoding same. Such antibodies are useful for the therapeutic and/or prophylactic treatment of ?v?3-mediated disorders, such as restenosis, in human patients.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: March 17, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Zdenka L Jonak, Kyung O Johanson, Alexander Taylor
  • Method for preparing a physiologically active IL-18 polypeptide
    Patent number: 7442526
    Abstract: The present invention provides a method for producing physiologically active human Interleukin-18 (“IL-18”).
    Type: Grant
    Filed: April 11, 2006
    Date of Patent: October 28, 2008
    Assignee: SmithKline Beecham Corporation
    Inventors: Kyung O. Johanson, Robert B. Kirkpatrick, Allan R. Shatzman, Yen Sen Ho, Patrick McDevitt
  • ANTI-ALPHABETA3 HUMANIZED MONOCLONAL ANTIBODIES
    Publication number: 20080160576
    Abstract: This invention relates to novel humanized and other recombinant or engineered antibodies or monoclonal antibodies to the vitronectin ?v?3 receptor and to the genes encoding same. Such antibodies are useful for the therapeutic and/or prophylactic treatment of ?v?3-mediated disorders, such as restenosis, in human patients.
    Type: Application
    Filed: April 25, 2007
    Publication date: July 3, 2008
    Inventors: Zdenka L. Jonak, Kyung O. Johanson, Alexander Taylor
  • Anti-alphabeta3 humanized monoclonal antibodies
    Patent number: 7230083
    Abstract: This invention relates to novel humanized and other recombinant or engineered antibodies or monoclonal antibodies to the vitronectin ?v?3 receptor and to the genes encoding same. Such antibodies are useful for the therapeutic and/or prophylactic treatment of ?v?3-mediated disorders, such as restenosis, in human patients.
    Type: Grant
    Filed: August 20, 2002
    Date of Patent: June 12, 2007
    Assignee: SmithKline Beecham Corporation
    Inventors: Zdenka L Jonak, Kyung O Johanson, Alexander Taylor
  • Nucleic acids encoding anti-human ???3 and ???5 antibodies
    Patent number: 7087405
    Abstract: This invention relates to novel humanized and other recombinant or engineered antibodies or monoclonal antibodies to a human ?v subunit-containing heterodimeric integrin receptors and to the genes encoding same. Such antibodies are useful for the therapeutic and/or prophylactic treatment of disorders mediated by such receptors, such as cancer, in human patients.
    Type: Grant
    Filed: May 9, 2002
    Date of Patent: August 8, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Kyung O Johanson, Zdenka Ludmila Jonak, Alexander Taylor, Stephen H Trulli
  • Anti-alphabeta3 humanized monoclonal antibodies
    Publication number: 20030152571
    Abstract: This invention relates to novel humanized and other recombinant or engineered antibodies or monoclonal antibodies to the vitronectin &agr;v&bgr;3-receptor and to the genes encoding same. Such antibodies are useful for the therapeutic and/or prophylactic treatment of &agr;v&bgr;3-mediated disorders, such as restenosis, in human patients.
    Type: Application
    Filed: August 20, 2002
    Publication date: August 14, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: Zdenka L. Jonak, Kyung O. Johanson, Alexander Taylor
  • Method for preparing a physiologically active il-18 polypeptide
    Publication number: 20030143198
    Abstract: A method for producing a physiologically active polypeptide, comprising contacting a precursor polypeptide with an activating enzyme, or co-expressing the polypeptide with an activating protease.
    Type: Application
    Filed: December 16, 2002
    Publication date: July 31, 2003
    Inventors: Kyung O Johanson, Robert B Kirkpatrick, Allan R Shatzman, Yen Sen Ho, Patrick McDevitt
  • Nucleic acids encoding anti-human alphanubeta3 and alphanubeta5 antibodies
    Publication number: 20030004317
    Abstract: This invention relates to novel humanized and other recombinant or engineered antibodies or monoclonal antibodies to a human &agr;v subunit-containing heterodimeric integrin receptors and to the genes encoding same. Such antibodies are useful for the therapeutic and/or prophylactic treatment of disorders mediated by such receptors, such as cancer, in human patients.
    Type: Application
    Filed: May 9, 2002
    Publication date: January 2, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: Kyung O. Johanson, Zdenka Ludmila Jonak, Alexander Taylor, Stephen H. Trulli
  • Anti-human .alpha..sub.v .beta..sub.3 and .alpha..sub.v .beta..sub.5 antibodies
    Patent number: 6160099
    Abstract: This invention relates to novel humanized and other recombinant or engineered antibodies or monoclonal antibodies to a human .alpha..sub.v subunit-containing heterodimeric integrin receptors and to the genes encoding same. Such antibodies are useful for the therapeutic and/or prophylactic treatment of disorders mediated by such receptors, such as cancer, in human patients.
    Type: Grant
    Filed: November 24, 1998
    Date of Patent: December 12, 2000
    Inventors: Zdenka Ludmila Jonak, Alexander Taylor, Stephen H Trulli, Kyung O Johanson